Jones Lang LaSalle Incorporated Common Stock (NY:JLL)

300.61 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jones Lang LaSalle Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Peering Into Jones Lang LaSalle's Recent Short Interest ↗

April 30, 2025

Via Benzinga

$1000 Invested In Jones Lang LaSalle 5 Years Ago Would Be Worth This Much Today ↗

April 30, 2025

Via Benzinga

Real Estate Services Stocks Q4 Recap: Benchmarking JLL (NYSE:JLL)

April 14, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the real estate services industry, including JLL (NYSE:JLL) and its peers.

Via StockStory

Q4 Earnings Highs And Lows: Zillow (NASDAQ:ZG) Vs The Rest Of The Real Estate Services Stocks

April 09, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the real estate services industry, including Zillow (NASDAQ:ZG) and its peers.

Via StockStory

How Do Investors Really Feel About Jones Lang LaSalle? ↗

March 06, 2025

Via Benzinga

Here's How Much $1000 Invested In Jones Lang LaSalle 20 Years Ago Would Be Worth Today ↗

February 28, 2025

Via Benzinga

Earnings Scheduled For February 19, 2025 ↗

February 19, 2025

Via Benzinga

$100 Invested In Jones Lang LaSalle 20 Years Ago Would Be Worth This Much Today ↗

February 10, 2025

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗

April 04, 2025

Via Benzinga

3 Reasons to Sell JLL and 1 Stock to Buy Instead

April 03, 2025

JLL trades at $244.01 per share and has stayed right on track with the overall market, losing 7.8% over the last six months while the S&P 500 is down 3.4%. This might have investors contemplating their...

Via StockStory

Topics Stocks

$100 Invested In Jones Lang LaSalle 5 Years Ago Would Be Worth This Much Today ↗

April 01, 2025

Via Benzinga

What's Driving the Market Sentiment Around Jones Lang LaSalle? ↗

March 25, 2025

Via Benzinga

Real Estate Services Stocks Q4 Teardown: Marcus & Millichap (NYSE:MMI) Vs The Rest

March 25, 2025

Let’s dig into the relative performance of Marcus & Millichap (NYSE:MMI) and its peers as we unravel the now-completed Q4 real estate services earnings season.

Via StockStory

(JLL) - Analyzing Jones Lang LaSalle's Short Interest ↗

February 10, 2025

Via Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today ↗

January 24, 2025

Via Benzinga

Looking Into Jones Lang LaSalle's Recent Short Interest ↗

January 17, 2025

Via Benzinga

Jones Lang LaSalle Expands Into Renewables With Javelin Capital Acquisition: Details ↗

March 24, 2025

JLL to acquire Javelin Capital, a leading renewable energy investment bank, enhancing its Energy & Infrastructure Capital Markets presence in the US and expanding its capabilities for major investors.

Via Benzinga

Real Estate Services Stocks Q4 In Review: Compass (NYSE:COMP) Vs Peers

March 14, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Compass (NYSE:COMP) and its peers.

Via StockStory

Here's How Much $100 Invested In Jones Lang LaSalle 5 Years Ago Would Be Worth Today ↗

March 12, 2025

Via Benzinga

The Office Market Will Rebound (Eventually) ↗

March 08, 2025

All told, it’s a changed office world since 2019. And we need to roll with the punches if we want to keep our money, much less make more. Here's why I believe the office market will rebound -- if given...

Via Talk Markets

Topics Real Estate & REITs

Motown Sports Group Holdings, Inc. Boosts Strategic Leadership with the Appointment of Joe F. Martinez, CEO of Core Venture Partners, LLC, to the Board of Directors

February 28, 2025

From Motown Sports Group Holdings, Inc.

Via GlobeNewswire

Offerpad (OPAD) Q4 Earnings: What To Expect

February 23, 2025

Technology real estate company Offerpad (NYSE:OPAD) will be announcing earnings results tomorrow after the bell. Here’s what to look for.

Via StockStory

eXp World (EXPI) Reports Earnings Tomorrow: What To Expect

February 19, 2025

Real estate technology company eXp World (NASDAQ:EXPI) will be reporting results tomorrow after market hours. Here’s what investors should know.

Via StockStory

Cushman & Wakefield Earnings: What To Look For From CWK

February 19, 2025

Real estate services firm Cushman & Wakefield (NYSE:CWK) will be announcing earnings results tomorrow before the bell. Here’s what to look for.

Via StockStory

What To Expect From RE/MAX’s (RMAX) Q4 Earnings

February 19, 2025

Real estate franchise company RE/MAX (NYSE:RMAX) will be announcing earnings results tomorrow afternoon. Here’s what to look for.

Via StockStory

JLL (NYSE:JLL) Exceeds Q4 Expectations

February 19, 2025

Real estate firm JLL (NYSE:JLL) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 15.8% year on year to $6.81 billion. Its non-GAAP profit of $6.15 per share was...

Via StockStory

JLL (JLL) Q4 Earnings Report Preview: What To Look For

February 18, 2025

Real estate firm JLL (NYSE:JLL) will be announcing earnings results tomorrow before the bell. Here’s what you need to know.

Via StockStory

Long Live (Some) Office Buildings ↗

February 08, 2025

Despite warming to the idea that office space wasn’t going away altogether, analysts have remained skeptical about how much value they could actually claw back. Even in 2025, most people aren’t rushing...

Via Talk Markets

Topics Real Estate & REITs

The Real Brokerage (NASDAQ:REAX) Q3 Earnings: Leading The Real Estate Services Pack

February 06, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the real estate services industry, including The Real Brokerage (NASDAQ:REAX) and its peers.

Via StockStory

Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies

January 21, 2025

Cell BioEngines Joins Center for Engineering and Precision Medicine (CEPM), Expands Relationship with Mount Sinai

From Cell BioEngines, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.